Pharmacogenomics and Herb-drug Interactions: Merge of Future and Tradition

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2015 Mar 31

PMID 25821484

Citations 17

Authors

Mou-Ze Liu

Yue-Li Zhang

Mei-Zi Zeng

Fa-Zhong He

Zhi-Ying Luo

Jian-Quan Luo

Jia-Gen Wen

Xiao-Ping Chen

Hong-Hao Zhou

Wei Zhang

Affiliations

Soon will be listed here.

Abstract

The worldwide using of herb products and the increasing potential herb-drug interaction issue has raised enthusiasm on discovering the underlying mechanisms. Previous review indicated that the interactions may be mediated by metabolism enzymes and transporters in pharmacokinetic pathways. On the other hand, an increasing number of studies found that genetic variations showed some influence on herb-drug interaction effects whereas these genetic factors did not draw much attention in history. We highlight that pharmacogenomics may involve the pharmacokinetic or pharmacodynamic pathways to affect herb-drug interaction. We are here to make an updated review focused on some common herb-drug interactions in association with genetic variations, with the aim to help safe use of herbal medicines in different individuals in the clinic.

Citing Articles

Changes in Pharmacokinetics and Pharmacodynamics of Losartan in Experimental Diseased Rats Treated with and .

Ahad A, Raish M, Abdelrahman I, Bin Jardan Y, Alam M, Al-Mohizea A Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678530 PMC: 9862944. DOI: 10.3390/ph16010033.

The Hepatoprotective and Anti-Nephrotoxic Potential of Methanolic Extract of a Polyherbal Preparation in CCl-Induced Liver Injury Model of Wistar Rats.

Boota M, Shah S, Rashid A, Akram M, Ayaz S, Mustafa I Dose Response. 2022; 20(3):15593258221124728.

PMID: 36158739 PMC: 9500276. DOI: 10.1177/15593258221124728.

Perilla Fruit Water Extract Attenuates Inflammatory Responses and Alleviates Neutrophil Recruitment via MAPK/JNK-AP-1/c-Fos Signaling Pathway in ARDS Animal Model.

Ting N, Chen Y, Chen J, Huang W, Liou C, Chen L Evid Based Complement Alternat Med. 2022; 2022:4444513.

PMID: 35815275 PMC: 9262517. DOI: 10.1155/2022/4444513.

Healthcare Professionals' Knowledge and Behaviors Regarding Drug-Dietary Supplement and Drug-Herbal Product Interactions.

Stanojevic-Ristic Z, Mrkic I, Corac A, Dejanovic M, Mitic R, Vitkovic L Int J Environ Res Public Health. 2022; 19(7).

PMID: 35409970 PMC: 8998985. DOI: 10.3390/ijerph19074290.

UPLC-MS/MS for the Herb-Drug Interactions of Xiao-Ai-Ping Injection on Enasidenib in Rats Based on Pharmacokinetics.

Wang B, Qiu C, Tang C, Zhang J, Zhang Y, Du Q Biomed Res Int. 2021; 2021:6636266.

PMID: 33688498 PMC: 7925021. DOI: 10.1155/2021/6636266.

References

Hu M, Wang D, Xiao Y, Mak V, Tomlinson B . Herb-drug interactions: methods to identify potential influence of genetic variations in genes encoding drug metabolizing enzymes and drug transporters. Curr Pharm Biotechnol. 2011; 13(9):1718-30. DOI: 10.2174/138920112800958805. View

Chen X, Sneed K, Pan S, Cao C, Kanwar J, Chew H . Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab. 2012; 13(5):640-51. DOI: 10.2174/1389200211209050640. View

Zhang Z, Ge B, Zhou L, Lam T, Zuo Z . Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin. J Ethnopharmacol. 2014; 154(3):672-86. DOI: 10.1016/j.jep.2014.04.047. View

Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M . Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. Fundam Clin Pharmacol. 2009; 23(3):359-65. DOI: 10.1111/j.1472-8206.2009.00681.x. View

Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T . Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes. J Clin Pharmacol. 2005; 45(6):690-4. DOI: 10.1177/0091270005275430. View

Shao J, Jia L . Potential serious interactions between nutraceutical ginseng and warfarin in patients with ischemic stroke. Trends Pharmacol Sci. 2013; 34(2):85-6. DOI: 10.1016/j.tips.2012.11.008. View

Li X, Hu J, Wang B, Sheng L, Liu Z, Yang S . Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. Toxicol Appl Pharmacol. 2014; 275(2):163-75. DOI: 10.1016/j.taap.2013.12.015. View

Tian X, Cheng Z, Jin H, Gao J, Qiao H . Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats. Evid Based Complement Alternat Med. 2013; 2013:179643. PMC: 3655607. DOI: 10.1155/2013/179643. View

Wang L, Zhou G, Zhu B, Wu J, Wang J, Abd El-Aty A . St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther. 2004; 75(3):191-7. DOI: 10.1016/j.clpt.2003.09.014. View

10.

Van Strater A, Bogers J . Interaction of St John's wort (Hypericum perforatum) with clozapine. Int Clin Psychopharmacol. 2011; 27(2):121-4. DOI: 10.1097/YIC.0b013e32834e8afd. View

11.

EISENBERG D, Kessler R, Foster C, Norlock F, Calkins D, Delbanco T . Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993; 328(4):246-52. DOI: 10.1056/NEJM199301283280406. View

12.

Imanaga J, Kotegawa T, Imai H, Tsutsumi K, Yoshizato T, Ohyama T . The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics. 2011; 21(2):84-93. DOI: 10.1097/fpc.0b013e32834300cc. View

13.

Xu H, Williams K, Liauw W, Murray M, Day R, McLachlan A . Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol. 2008; 153(7):1579-86. PMC: 2437900. DOI: 10.1038/sj.bjp.0707685. View

14.

Kim J, Kim S, Song I, Shin H, Kim H, Lee J . Different transport activity of human triallelic MDR1 893Ala/Ser/Thr variant and its association with herb extracts. Phytother Res. 2011; 25(8):1141-7. DOI: 10.1002/ptr.3405. View

15.

Song M, Hong M, Lee M, Jee J, Lee Y, Bae J . Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Food Chem Toxicol. 2013; 59:549-53. DOI: 10.1016/j.fct.2013.06.055. View

16.

Yin O, Tomlinson B, Waye M, Chow A, Chow M . Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics. 2004; 14(12):841-50. DOI: 10.1097/00008571-200412000-00007. View

17.

Mohammed Abdul M, Jiang X, Williams K, Day R, Roufogalis B, Liauw W . Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008; 154(8):1691-700. PMC: 2518459. DOI: 10.1038/bjp.2008.210. View

18.

Wang X, Li J, Su Q, Guan S, Chen J, Du J . Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme. Br J Clin Pharmacol. 2009; 67(2):255-61. PMC: 2670384. DOI: 10.1111/j.1365-2125.2008.03344.x. View

19.

Li X, Lian F, Guo D, Fan L, Tang J, Peng J . The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes. Evid Based Complement Alternat Med. 2013; 2013:327629. PMC: 3657408. DOI: 10.1155/2013/327629. View

20.

Nakao M, Muramoto Y, Hisadome M, Yamano N, Shoji M, Fukushima Y . The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6. Eur J Clin Pharmacol. 2007; 63(4):345-53. DOI: 10.1007/s00228-006-0253-5. View